Full-Time

Senior Scientist 2

Biotech

Deadline 2/4/27
Alcami

Alcami

51-200 employees

No salary listed

Durham, NC, USA

In Person

Category
Biology & Biotech (2)
,
Requirements
  • Bachelor’s degree in Biochemistry, Chemistry, or related field with minimum 10 years of experience
  • Master’s degree in Biochemistry, Chemistry, or related field with a minimum of 6 years’ experience
  • Doctoral degree in a related field with a minimum of 4 years’ experience
  • 5+ years of experience in Pharmaceutical/Biopharmaceutical analytical drug product development under cGMP is required
  • Demonstrated experience in development, validation and troubleshooting chromatographic, electrophoretic, mass spectrometry and other spectroscopic methods for peptides, monoclonal antibodies/recombinant proteins, nucleic acids, cell therapy and gene therapy
  • Up to 5% travel
Responsibilities
  • Demonstrates strong expertise in biochemistry, mass spectrometry, chemistry, and protein chemistry.
  • Develops and validates methods to determine purity, potency, identity, residuals, and characterization of pharmaceutical and biopharmaceutical products.
  • Supports analytical studies for peptides, proteins, nucleic acids, carbohydrates, cell & gene therapy products, as well as small molecule drugs in parenteral, solid dosage forms, transdermal patches, intermediates, and APIs.
  • Maintains an expert knowledge and mastery of equipment, instrumentation, procedures, and scientific methodologies necessary to perform complex research or projects.
  • Performs routine analytical procedures necessary for support of formulation development, manufacturing, and QC stability activities.
  • Documents results in electronic laboratory notebook.
  • Evaluates and interprets analytical data.
  • Writes standard operating procedures (SOPs), test procedures, specifications, protocols, project reports (e.g., development/validation), and client communications.
  • Positively interacts with team members, management, and clients to discuss data and project progress.
  • Leads deviations, investigations, and root cause analysis.
  • Participates in regulatory agency and/or client audits.
  • Maintains a safe, clean, and organized work environment free of safety hazards. Safely handles potent compounds.
  • Ensures timely completion and compliance with cGMP and all other relevant company training requirements.
  • Participates in scientific conferences and contributes to scientific journals.
  • Leads and mentors associate scientist(s).
  • Other duties as assigned.
Desired Qualifications
  • CDMO experience is preferred
  • Experience in molecular biology is a plus

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Pepperell, Massachusetts

Founded

1984

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquired Pacific Pharmaceutical Services in January 2024, expanding Nevada warehousing.
  • Garner facility expanded January 2025 with stability chambers and inventory management.
  • Backed by GHO Capital, Vistria Group, and Ampersand for CDMO growth.

What critics are saying

  • Patrick Walsh returns as interim CEO January 2025 after Humphries' two-year tenure.
  • No disclosed synergies from 2024 Pacific and 2021 Masy acquisitions erode margins.
  • Garner facility cannibalizes existing six-location network, compressing storage pricing.

What makes Alcami unique

  • Alcami integrates lab, manufacturing, and cGMP storage across six U.S. locations.
  • Garner facility offers cryogenic LN2, ultra-low freezer, and aliquoting services.
  • Acquired Masy Systems in 2021 for specialized biostorage and support.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Alcami who can refer or advise you

Benefits

Remote Work Options

Company News

PR Newswire
Jan 13th, 2025
Alcami Announces Ceo Transition

Long time industry leader, Chairman of the Board Patrick Walsh replaces CEO Bill Humphries DURHAM, N.C., Jan. 13, 2025 /PRNewswire/ -- Alcami Corporation ("Alcami"), a leading contract development and manufacturing organization (CDMO), today announced the resignation of Bill Humphries. Alcami's Board Chair and former Chief Executive Officer Patrick Walsh will serve as Interim CEO, ensuring the continuation of smooth operations and a strong client-centric approach from a proven industry veteran

PR Newswire
Jul 23rd, 2024
Alcami Unveils New Conditions And Services At State-Of-The-Art Pharma Storage Facility In Garner

"Alcami's new facility is well positioned to fill previously unmet market demand," said Laurent Boer, President, Alcami Pharma Storage and Services. "The pipeline of complex medicines – exactly the type of ground-breaking products that life science companies in RTP work on – is only increasing. The biopharmaceutical materials and products in these drugs require very specific warehouse conditions that this new facility provides. But what truly sets us apart as a CDMO is our ability to offer a comprehensive pharma storage network paired with seamless access to our integrated laboratory and manufacturing services. From development to delivery, Alcami has the capabilities to care for and secure product within our own network, reducing risk and streamlining efficiency."After opening in January with controlled/ambient storage, the facility can now accept shipments for an extensive range of storage conditions, including stability chamber storage, refrigerated storage, freezer, ultra-low freezer, and cryogenic storage (LN2) as well as custom conditions. In addition, the site now offers a full suite of materials management and support services that facilitate the full product development, storage, and commercialization journey, including onsite aliquoting/sampling in grade C sampling booths, refrigerated transport, labeling, cycle counting/inventory management, custom kitting, and reference standards management.The new central North Carolina facility adjacent to the Research Triangle Park expands Alcami's high-quality, secure GMP storage network to six U.S

Contract Pharma
Dec 15th, 2021
alcami acquires Masy Systems Inc.

Alcami Corp., a pharmaceutical and biotech contract development and manufacturing organization ( CDMO ), has completed the acquisition of Masy Systems Inc., a provider of cGMP biostorage and pharma support services.

PR Newswire
Dec 15th, 2021
AAIPharma Services Corp. acquired Masy Systems Inc. on Dec 15th 21'.

Alcami Corporation, a leading pharmaceutical and biotech contract development and manufacturing organization (CDMO), announced today it has completed the acquisition of Masy Systems Inc. ("Masy" or "Masy BioServices"), a preferred provider of cGMP Biostorage and pharma support services.

Daily Times Chronicle
Dec 1st, 2021
Masy Systems Inc. launches SenseAnywhere modules

Masy BioServices announces the launch of innovative SenseAnywhere modules.